Proven, respected, doctor recommended
Trusted neurologists from around the country have recommended Boston Scientific Deep Brain Stimulation (DBS) for treatment of Parkinson’s disease (PD). They believe in the results and the science behind our systems.
Hear from an expert
Dr. Jerold Vitek, Professor and Chair, Department of Neurology, University of Minnesota, talks about the difference of the Vercise™ DBS System.
How effective is DBS?
Not all people experience PD the same way or at the same progression. The severity, type, and recurrence of any symptom will vary from person to person—as will their response to DBS treatment. In general, DBS allows people living with PD to decrease their medications and experience fewer side effects, such as uncontrolled movements, incontinence, and moodiness.1
96% Patient Satisfaction
If given the chance, 96% of DBS patients would choose to do it again.2
More “ON Time”
DBS provides an additional 6 hours of "ON time" without troublesome dyskinesias compared to medication alone, giving people more control and independence to live life without rigidity or freezing.3
Marked improvements in motor function are sustained for at least 5 years.4
People with tremors experience an average of 70% reduction in tremors, depending on its type of location.5
One year after DBS, 75% of people reported a decrease in their Parkinson’s medication.6
At Boston Scientifc, it’s important we put our technology to the test. To do this, we conducted a multicenter, prospective, double blinded, randomized, trial for DBS, conducted at one-year follow-up appointments, called the INTREPID study.3
One year into treatment, those who used a Boston Scientific DBS System experienced a 51% improvement in their motor function3
DBS patients who used a Boston Scientific DBS System experienced meaningful improvements in their quality of life3
One year into treatment, Boston Scientific DBS patients experienced a 30% decrease in medication3
Over 90% of subjects and clinicians reported improvement in symptoms at 1 year.7
Results from different clinical investigations are not directly comparable. Information provided for educational purposes only.
References: 1. Timmermann L, Jain R, Chen L, et al. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson’s disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study. Lancet Neurol. 2015;14:693-701. doi: 10.1016/S1474-4422(15)00087-3 2. Knoop CD, Kadish R, Hager K, Park MC, Loprinzi PD, LaFaver K. Bridging the gap in patient education for DBS surgery for Parkinson’s disease. Parkinson’s Dis. 2017;2017:9360354. doi:10.1155/2017/9360354 3. Vitek JL, Jain R, Chen L, et al. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson’s disease (INTREPID): a multicenter, double-blind, randomised, sham-controlled study. Lancet Neurology. 2020;19(6):491‐501. doi:10.1016/S1474-4422(20)30108-3 4. Krack P, Batir A, Van Blercom, N. Five-year follow-up of bilateral stimulation of the subthalmic nucleus in advanced Parkinson’s disease. N Eng J Med. 2003:349(20):1925-1934. doi:10.1056/NEJMoa035275 5. Farris SM, Giroux, ML. (2013). DBS: A Patient Guide to Deep Brain Stimulation. 1st ed. CreateSpace Independent Publishing Platform; 2013. 6. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial. JAMA. 2009;301(1):63-73. doi:10.1001/jama.2008.929 7. Vitek, J. INTREPID Study. Presented by Robert Gross, Plenary Session, AANS Presented at: 2018 AANS; April 26-27, 2018; New Orleans, Louisiana, USA.